Use of Plasma or Serum SMOC2 as a Diagnostic Marker of Fibrosis and NASH
Patients can be screened by SMOC2 levels in plasma/serum to identify those for which a biopsy is relevant, and high risk patients
Published: 31st August 2022

Patents
- Priority IP application in 2022
Seeking
- Development partner
- Commercial partner